ArticleInternational journal of surgery (London, England)2026
Favorable outcome of immunotherapy use in metastatic HR+/HER2- breast cancer: a population-based cohort study.
Guansheng Zhong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.